The Morning Dispatch: FDA Approves Controversial Alzheimer’s Drug

Happy Thursday! Apologies if this newsletter is a little damp when it hits your inbox—the humidity in D.C. this week has been unbearable.

Quick Hits: Today’s Top Stories

  • The Washington Post reported Wednesday that the Biden administration is buying 500 million COVID-19 vaccine doses from Pfizer at a “not-for-profit” price, with plans to donate them to low- and middle-income countries around the world. Distribution will be run through the World Health Organization’s COVAX initiative, with 200 million doses going out this year, and 300 million in early 2022.

  • Months after President Biden revoked its necessary cross-border permit, the Keystone XL Pipeline’s developer formally abandoned the project, which was first proposed 13 years ago.

  • President Biden issued an executive order yesterday replacing former President Donald Trump’s attempts to ban Chinese-owned apps TikTok and WeChat with an even broader review of software applications developed in adversarial countries.

Join to continue reading
Get started with a free account or join as a member for unlimited access to all of The Dispatch. Continue ALREADY HAVE AN ACCOUNT? SIGN IN